UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

DISEASE IMPACT AND COST-EFFECTIVENESS OF A NEW DENGUE VACCINE TAK003 IN THAILAND

International journal of infectious diseases, 2023-05, Vol.130, p.S141-S141

2023

Volltextzugriff (PDF)

Burden of cytomegalovirus disease in allogeneic hematopoietic cell transplant recipients: a national, matched cohort study in an inpatient setting

Current research in translational medicine, 2018-11, Vol.66 (4), p.95-101

2018

Volltextzugriff (PDF)

Prescription patterns following First-Line Second-Generation Antipsychotics for patients with Schizophrenia in Japan: an Insurance claims database analysis

Value in health, 2015-05, Vol.18 (3), p.A129-A129

2015

Volltextzugriff (PDF)

Should Changes in Drug Price Over Time be Considered in Cost-Effectiveness Analyses?

Value in health, 2014-11, Vol.17 (7), p.A548-A548

2014

Volltextzugriff (PDF)

Population Access to Rotavirus Vaccination in Industrialized Countries: Lessons Learnt from Current Experience

Value in health, 2014-11, Vol.17 (7), p.A808-A808

2014

Volltextzugriff (PDF)

Cost burden analysis of relapse in prescription Opioid Drug dependent Patients treated with Buprenorphine/Naloxone and Patients without Pharmacological treatment

Value in health, 2015-05, Vol.18 (3), p.A121-A121

2015

Volltextzugriff (PDF)

Comparison of Economic Evaluation Guidelines Between Japan and Other Asian Countries

Value in health, 2014-11, Vol.17 (7), p.A798-A798

2014

Volltextzugriff (PDF)

Real Life Impact Of External Reference Pricing In Europe Using A Simulation Model

Value in health, 2014-05, Vol.17 (3), p.A14-A14

2014

Volltextzugriff (PDF)

A model simulating external reference pricing to support policy decision making in Europe

Value in health, 2014-05, Vol.17 (3), p.A192-A192

2014

Volltextzugriff (PDF)

Burden of Illness of Dementia in China

Value in health, 2014-11, Vol.17 (7), p.A767-A767

2014

Volltextzugriff (PDF)

Impact of Exclusive Hospital Distribution of Biosimilar on Drug Health Care Budget

Value in health, 2013-11, Vol.16 (7), p.A323-A323

2013

Volltextzugriff (PDF)

Drug Compliance and Persistence in Patients with Parkinson’s Disease Treated in Primary Care in the United Kingdom: A CPRD-Based Study

Value in health, 2013-11, Vol.16 (7), p.A628-A629

2013

Volltextzugriff (PDF)

Description of Treatment Pathways in Chronic Diseases Using Large General Practitioner Longitudinal Data: The Example of Pharmaco-Therapy in Parkinson’s Disease in the United Kingdom

Value in health, 2013-11, Vol.16 (7), p.A583-A583

2013

Volltextzugriff (PDF)

How Should an Antidepressant with Reduced Risk of Sexual Dysfunction Be Positioned in Treatment Strategies for Patients with Major Depressive Disorder?

Value in health, 2013-11, Vol.16 (7), p.A547-A548

2013

Volltextzugriff (PDF)

Bayesian Calibration Method to Estimate Transition Probabilities for a Markov Model Based on a Continuous Outcome Measure: Application in Parkinson’s Disease

Value in health, 2013-11, Vol.16 (7), p.A325-A326

2013

Volltextzugriff (PDF)

PIH49 Population Access to Rotavirus Vaccination in Developped Countries: Lessons Learned from Current Experience and Potential Implications for the Future

Value in health, 2012-11, Vol.15 (7), p.A545-A545

2012

Volltextzugriff (PDF)

PMH10 Patient Persistence With Buprenorhine/Naloxone Film and Tablet Formulations in the Treatment of Opioid Dependence in the United States: Results From a Large Privately Insured Retrospective Database

Value in health, 2012-11, Vol.15 (7), p.A335-A335

2012

Volltextzugriff (PDF)

PHS81 Health Care Organizations/Services Clustering: Comparison of Several Techniques Using UK Data

Value in health, 2012-11, Vol.15 (7), p.A532-A533

2012

Volltextzugriff (PDF)

PHP133 Market Access of Drugs in France and Medico-Economic Assessment

Value in health, 2012-11, Vol.15 (7), p.A312-A312

2012

Volltextzugriff (PDF)

Elicitation of health-related quality of life concepts associated with peripheral neuropathy

Value in health, 2014-05, Vol.17 (3), p.A199-A199

2014

Volltextzugriff (PDF)

Identification Of Reasons For Non-Adherence And Elicitation Of Health-Related Quality Of Life Concepts Associated With Immunosuppressant Therapy In Kidney Transplant Recipients

Value in health, 2014-05, Vol.17 (3), p.A294-A294

2014

Volltextzugriff (PDF)

PMH9 Description of the Burden Associated with Cognition Deficits in Schizophrenia

Value in health, 2012-06, Vol.15 (4), p.A82-A83

2012

Volltextzugriff (PDF)

PMH62 Predominant Negative Symptoms in Schizophrenia

Value in health, 2012-06, Vol.15 (4), p.A93-A93

2012

Volltextzugriff (PDF)

Pharmaceutical Expenditure Forecast Model To Support Health Policy Decision Making

Value in health, 2013-05, Vol.16 (3), p.A255-A255

2013

Volltextzugriff (PDF)

Innovative Methodology For Pharmaceutical Expenditure Forecast

Value in health, 2013-05, Vol.16 (3), p.A256-A256

2013

Volltextzugriff (PDF)

1 – 25 von 532

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(489)
Mit Volltextzugriff
(452)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

DISEASE IMPACT AND COST-EFFECTIVENESS OF A NEW DENGUE VACCINE TAK003 IN THAILAND

Burden of cytomegalovirus disease in allogeneic hematopoietic cell transplant recipients: a national, matched cohort study in an inpatient setting

Prescription patterns following First-Line Second-Generation Antipsychotics for patients with Schizophrenia in Japan: an Insurance claims database analysis

Should Changes in Drug Price Over Time be Considered in Cost-Effectiveness Analyses?

Population Access to Rotavirus Vaccination in Industrialized Countries: Lessons Learnt from Current Experience

Cost burden analysis of relapse in prescription Opioid Drug dependent Patients treated with Buprenorphine/Naloxone and Patients without Pharmacological treatment

Comparison of Economic Evaluation Guidelines Between Japan and Other Asian Countries

Real Life Impact Of External Reference Pricing In Europe Using A Simulation Model

A model simulating external reference pricing to support policy decision making in Europe

Burden of Illness of Dementia in China

Impact of Exclusive Hospital Distribution of Biosimilar on Drug Health Care Budget

Drug Compliance and Persistence in Patients with Parkinson’s Disease Treated in Primary Care in the United Kingdom: A CPRD-Based Study

Description of Treatment Pathways in Chronic Diseases Using Large General Practitioner Longitudinal Data: The Example of Pharmaco-Therapy in Parkinson’s Disease in the United Kingdom

How Should an Antidepressant with Reduced Risk of Sexual Dysfunction Be Positioned in Treatment Strategies for Patients with Major Depressive Disorder?

Bayesian Calibration Method to Estimate Transition Probabilities for a Markov Model Based on a Continuous Outcome Measure: Application in Parkinson’s Disease

PIH49 Population Access to Rotavirus Vaccination in Developped Countries: Lessons Learned from Current Experience and Potential Implications for the Future

PMH10 Patient Persistence With Buprenorhine/Naloxone Film and Tablet Formulations in the Treatment of Opioid Dependence in the United States: Results From a Large Privately Insured Retrospective Database

PHS81 Health Care Organizations/Services Clustering: Comparison of Several Techniques Using UK Data

PHP133 Market Access of Drugs in France and Medico-Economic Assessment

Elicitation of health-related quality of life concepts associated with peripheral neuropathy

Identification Of Reasons For Non-Adherence And Elicitation Of Health-Related Quality Of Life Concepts Associated With Immunosuppressant Therapy In Kidney Transplant Recipients

PMH9 Description of the Burden Associated with Cognition Deficits in Schizophrenia

PMH62 Predominant Negative Symptoms in Schizophrenia

Pharmaceutical Expenditure Forecast Model To Support Health Policy Decision Making

Innovative Methodology For Pharmaceutical Expenditure Forecast

Suchergebnisse filtern